Skip to content

Clinical trials

Phase 1 Diabetes Mellitus trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 1 Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20062
20071
20081
20102
20131
20161
20172
20181
20211
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting2
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alberta4
CRISPR Therapeutics AG2
Encellin2
Montreal Heart Institute2
University of Toronto2
C. T. Lamont Primary Care Research Centre1
GAAD Medical Research Institute Inc.1
Housey Healthcare ULC1
McGill University1
Neurocrine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus22
Diabetes Mellitus, Type 17
Diabetes Mellitus, Type 25
Cardiovascular Diseases4
Obesity4
Hypertension3
Autoimmune Diseases2
Endocrine System Diseases2
Glucose Metabolism Disorders2
Immune System Diseases2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.